Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Némati, Fariba"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Montaudon E; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France., El Botty R; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France., Vacher S; Department of Genetics, Institut Curie, Paris, France., Déas O; Xentech, Evry, France., Naguez A; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France., Chateau-Joubert S; BioPôle Alfort, National Veterinary School of Alfort, Maisons Alfort, France., Treguer D; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France., de Plater L; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France., Zemoura L; Department of Pathology, Hôpital Foch, Suresnes, France., Némati F; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France., Nicolas A; Department of Tumor Biology, Institut Curie, Paris, France., Chapelier A; Department of Thoracic Surgery, Hôpital Foch, Suresnes, France., Livartowski A; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France., Cairo S; Xentech, Evry, France., Daniel C; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France., Brevet M; CYPATH, Centre Léon Bérard, Lyon, France., Marangoni E; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France., Meseure D; Department of Tumor Biology, Institut Curie, Paris, France., Roman-Roman S; Department of Translational Research, Institut Curie, PSL University, Paris, France., Bieche I; Department of Genetics, Institut Curie, Paris, France.; These authors contributed equally to this work., Girard N; Institut du Thorax Curie Montsouris, Institut Curie, Paris, France.; These authors contributed equally to this work., Decaudin D; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University, Paris, France.; Department of Medical Oncology, Institut Curie, Paris, France.; These authors contributed equally to this work.
Publikováno v:
Oncotarget [Oncotarget] 2021 Apr 13; Vol. 12 (8), pp. 859-872. Date of Electronic Publication: 2021 Apr 13 (Print Publication: 2021).
Autor:
Maubant S; Institut Curie, PSL Research University, Translational Research Department, Breast Cancer Biology Group, Paris, France., Tahtouh T; Institut Curie, PSL Research University, Translational Research Department, Breast Cancer Biology Group, Paris, France., Brisson A; Institut Curie, PSL Research University, Translational Research Department, Breast Cancer Biology Group, Paris, France., Maire V; Institut Curie, PSL Research University, Translational Research Department, Breast Cancer Biology Group, Paris, France., Némati F; Institut Curie, PSL Research University, Translational Research Department, Preclinical Investigation Laboratory, Paris, France., Tesson B; Institut Curie, PSL Research University, Translational Research Department, Breast Cancer Biology Group, Paris, France.; Institut Curie, PSL Research University, INSERM U900, Paris, France., Ye M; Institut Curie, PSL Research University, Translational Research Department, Breast Cancer Biology Group, Paris, France., Rigaill G; Institute of Plant Sciences Paris-Saclay (IPS2), UMR 9213/UMR 1403, CNRS, INRA, Université Paris-Sud, Université d'Evry, Université Paris-Diderot, Sorbonne Paris-Cité, Orsay, France.; Laboratoire de Mathématiques et Modélisation d'Evry (LaMME), Université d'Evry Val d'Essonne, UMR CNRS 8071, ENSIIE, USC INRA, Évry, France., Noizet M; Institut Curie, PSL Research University, Translational Research Department, Breast Cancer Biology Group, Paris, France., Dumont A; Institut Curie, PSL Research University, Translational Research Department, Breast Cancer Biology Group, Paris, France., Gentien D; Institut Curie, PSL Research University, Translational Research Department, Genomics Platform, Paris, France., Marty-Prouvost B; Institut Curie, PSL Research University, Translational Research Department, Breast Cancer Biology Group, Paris, France., de Koning L; Institut Curie, PSL Research University, Translational Research Department, Reverse-Phase Protein Array Platform, Paris, France., Mahmood SF; Institut Curie, PSL Research University, Translational Research Department, Breast Cancer Biology Group, Paris, France., Decaudin D; Institut Curie, PSL Research University, Translational Research Department, Preclinical Investigation Laboratory, Paris, France., Cruzalegui F; Oncology Research and Development Unit, Institut de Recherches SERVIER, Croissy-Sur-Seine, France., Tucker GC; Oncology Research and Development Unit, Institut de Recherches SERVIER, Croissy-Sur-Seine, France., Roman-Roman S; Institut Curie, PSL Research University, Translational Research Department, Paris, France., Dubois T; Institut Curie, PSL Research University, Translational Research Department, Breast Cancer Biology Group, Paris, France.
Publikováno v:
Oncotarget [Oncotarget] 2018 Apr 27; Vol. 9 (32), pp. 22586-22604. Date of Electronic Publication: 2018 Apr 27 (Print Publication: 2018).
Autor:
Decaudin D; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, Paris, France.; Department of Medical Oncology, Institut Curie, Paris, France., El Botty R; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, Paris, France., Diallo B; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, Paris, France., Massonnet G; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, Paris, France., Fleury J; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, Paris, France., Naguez A; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, Paris, France., Raymondie C; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, Paris, France., Davies E; IMED Oncology, AstraZeneca, Cambridge, UK., Smith A; IMED Oncology, AstraZeneca, Cambridge, UK., Wilson J; IMED Oncology, AstraZeneca, Cambridge, UK., Howes C; IMED Oncology, AstraZeneca, Cambridge, UK., Smith PD; IMED Oncology, AstraZeneca, Cambridge, UK., Cassoux N; Department of Oncological Ophthalmology, Institut Curie, Paris, France., Piperno-Neumann S; Department of Medical Oncology, Institut Curie, Paris, France., Roman-Roman S; Department of Translational Research, Institut Curie, PSL University Paris, Paris, France., Némati F; Laboratory of Preclinical Investigation, Department of Translational Research, Institut Curie, PSL University Paris, Paris, France.
Publikováno v:
Oncotarget [Oncotarget] 2018 Apr 24; Vol. 9 (31), pp. 21674-21686. Date of Electronic Publication: 2018 Apr 24 (Print Publication: 2018).